Electroporation: An Effective Method For In Vivo Gene Delivery

Q2 Pharmacology, Toxicology and Pharmaceutics Drug Delivery Letters Pub Date : 2022-01-27 DOI:10.2174/2210303112666220127113328
A. Nikyar, A. Bolhassani
{"title":"Electroporation: An Effective Method For In Vivo Gene Delivery","authors":"A. Nikyar, A. Bolhassani","doi":"10.2174/2210303112666220127113328","DOIUrl":null,"url":null,"abstract":"\n\nGene therapy is a promising approach for the treatment of various diseases including cancer, hereditary disorders, and some viral infections. Development of efficient and safe gene delivery systems is essential for facilitating gene transfer to various organs and tissues in vivo.\n\n\n\nIn this review, we briefly describe the principal mechanisms of gene delivery systems, particularly electroporation, and discuss the latest advancements in the application of electroporation for in vivo gene transfer.\n\n\n\nA narrative review of all the relevant publication known to the authors was conducted.\n\n\n\nIn recent years, electroporation-based strategies have emerged as an auspicious and versatile platform for efficient and controlled delivery of various biomolecules, including nucleic acids. Applying electric pulses of enough magnitude leads to the formation of hydrophilic pores in the cell membrane and allows the entry of otherwise membrane-impermeant molecules, such as DNA. Although electroporation has been initially developed for in vitro transfection of cells, it has recently advanced to preclinical in vivo applications and finally to clinical trials.\n\n\n\nElectroporation has already entered the clinical practice for antitumor therapy and may be an essential part of future personalized treatments. Given the ability of electroporation to deliver multiple genes in a single event, it will also certainly be further developed both as a stand-alone delivery approach and when coupled with other technologies.\n","PeriodicalId":11310,"journal":{"name":"Drug Delivery Letters","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Delivery Letters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2210303112666220127113328","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Gene therapy is a promising approach for the treatment of various diseases including cancer, hereditary disorders, and some viral infections. Development of efficient and safe gene delivery systems is essential for facilitating gene transfer to various organs and tissues in vivo. In this review, we briefly describe the principal mechanisms of gene delivery systems, particularly electroporation, and discuss the latest advancements in the application of electroporation for in vivo gene transfer. A narrative review of all the relevant publication known to the authors was conducted. In recent years, electroporation-based strategies have emerged as an auspicious and versatile platform for efficient and controlled delivery of various biomolecules, including nucleic acids. Applying electric pulses of enough magnitude leads to the formation of hydrophilic pores in the cell membrane and allows the entry of otherwise membrane-impermeant molecules, such as DNA. Although electroporation has been initially developed for in vitro transfection of cells, it has recently advanced to preclinical in vivo applications and finally to clinical trials. Electroporation has already entered the clinical practice for antitumor therapy and may be an essential part of future personalized treatments. Given the ability of electroporation to deliver multiple genes in a single event, it will also certainly be further developed both as a stand-alone delivery approach and when coupled with other technologies.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
电穿孔:一种有效的体内基因传递方法
基因治疗是一种很有前途的治疗各种疾病的方法,包括癌症、遗传性疾病和一些病毒感染。开发高效、安全的基因传递系统是促进基因向体内各种器官和组织转移的必要条件。本文简要介绍了基因传递系统的主要机制,特别是电穿孔,并讨论了电穿孔在体内基因转移中的最新应用进展。对作者所知的所有相关出版物进行了叙述性审查。近年来,基于电穿孔的策略已经成为一种吉祥和通用的平台,用于有效和控制各种生物分子的递送,包括核酸。施加足够大的电脉冲会导致细胞膜上形成亲水孔,并允许细胞膜上不需要的分子(如DNA)进入。虽然电穿孔最初是为了细胞的体外转染而发展起来的,但它最近已经发展到临床前的体内应用,并最终进入临床试验。电穿孔已经进入临床抗肿瘤治疗,并可能成为未来个性化治疗的重要组成部分。考虑到电穿孔在一次事件中传递多个基因的能力,它当然也将进一步发展为一种独立的传递方法,并与其他技术结合使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Drug Delivery Letters
Drug Delivery Letters Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
CiteScore
1.70
自引率
0.00%
发文量
30
期刊最新文献
In-vitro and In-silico Examinations on Baicalein-loaded Solid Lipid Nanoparticles for Neurodegeneration D-Optimal Mixture Design Enabled Development of Lyophilized Nanoemulsifying Drug Delivery System of Paliperidone Intranasal Route an Alternative Approach for Systemic Drug Delivery: Recent Strategies and Progression Revolutionizing Nitrofurantoin Delivery: Unraveling Challenges and Pioneering Solutions for Enhanced Efficacy in UTI Treatment Hot Melt Extrusion Technique for Developing Pharmaceutical Co-crystals: A Review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1